Literature DB >> 33738713

Clinical Outcomes and Immune Metrics in Intratumoral Basophil-Enriched Gastric Cancer Patients.

Xudong He1, Yifan Cao2, Yun Gu1, Hanji Fang1, Jieti Wang3, Xin Liu1, Kunpeng Lv1, Kuan Yu2, Yuchao Fei1, Chao Lin2, Hao Liu2, Heng Zhang2, He Li2, Jiejie Xu1, Ruochen Li4, Hongyong He5.   

Abstract

BACKGROUND: Accumulation of basophils has been reported in several malignancies. In gastric cancer, the relation between tumor-infiltrating basophils and patient overall survival and chemotherapeutic responsiveness still remains obscure.
OBJECTIVE: We aimed to investigate the postoperative prognostic and predictive significance of basophils to survival outcomes and chemotherapeutic responsiveness in resectable gastric cancer.
METHODS: The study enrolled two independent patient data sets with 448 gastric cancer patients overall. Basophils were evaluated with the use of immunohistochemistry (IHC) staining, and the correlation with clinicopathological characteristics, survival outcomes, and responsiveness to fluorouracil-based adjuvant chemotherapy (ACT) were investigated. Additionally, IHC was applied to characterize immune contexture in gastric cancer.
RESULTS: In either the discovery or validation data sets, accumulated basophils indicated poorer prognosis, and tumor-infiltrating basophils were identified as an independent adverse prognostic factor by multivariate analysis. Furthermore, tumor-infiltrating basophils determined significantly inferior therapeutic responsiveness to fluorouracil-based ACT in patients with stage III tumors. In addition, the abundance of basophils was correlated with an immunoevasive contexture characterized by M2-polarized macrophage infiltration. Moreover, our findings indicated elevated interleukin-4 expression but decreased interferon-γ expression in the high-basophils subgroup.
CONCLUSIONS: Tumor-infiltrating basophils in gastric cancer were identified as an independent adverse prognosticator, and also predicted inferior chemotherapeutic responsiveness, which identified those patients in need of much more individualized postoperative adjuvant therapy and more stringent follow-up. Furthermore, the infiltration of basophils was associated with immunoevasive tumor microenvironment, which might be a potential immunotherapeutic target for gastric cancer.

Entities:  

Year:  2021        PMID: 33738713     DOI: 10.1245/s10434-021-09815-0

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  34 in total

1.  Basophils play a critical role in the development of IgE-mediated chronic allergic inflammation independently of T cells and mast cells.

Authors:  Kaori Mukai; Kunie Matsuoka; Choji Taya; Hidenori Suzuki; Hiroo Yokozeki; Kiyoshi Nishioka; Katsuiku Hirokawa; Maki Etori; Makoto Yamashita; Toshiyuki Kubota; Yoshiyuki Minegishi; Hiromichi Yonekawa; Hajime Karasuyama
Journal:  Immunity       Date:  2005-08       Impact factor: 31.745

2.  A mechanism for the initiation of allergen-induced T helper type 2 responses.

Authors:  Caroline L Sokol; Gregory M Barton; Andrew G Farr; Ruslan Medzhitov
Journal:  Nat Immunol       Date:  2008-03       Impact factor: 25.606

3.  Basophils enhance immunological memory responses.

Authors:  Andrea Denzel; Ulrich A Maus; Manuel Rodriguez Gomez; Cordula Moll; Marianne Niedermeier; Christine Winter; Regina Maus; Susan Hollingshead; David E Briles; Leoni A Kunz-Schughart; Yvonne Talke; Matthias Mack
Journal:  Nat Immunol       Date:  2008-05-30       Impact factor: 25.606

4.  Basophils orchestrate chronic allergic dermatitis and protective immunity against helminths.

Authors:  Caspar Ohnmacht; Christian Schwartz; Marc Panzer; Isabell Schiedewitz; Ronald Naumann; David Voehringer
Journal:  Immunity       Date:  2010-09-24       Impact factor: 31.745

5.  Basophils are essential initiators of a novel type of chronic allergic inflammation.

Authors:  Kazushige Obata; Kaori Mukai; Yusuke Tsujimura; Kenji Ishiwata; Yohei Kawano; Yoshiyuki Minegishi; Naohiro Watanabe; Hajime Karasuyama
Journal:  Blood       Date:  2007-04-04       Impact factor: 22.113

6.  Cancer statistics, 2020.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2020-01-08       Impact factor: 508.702

7.  Global cancer statistics, 2012.

Authors:  Lindsey A Torre; Freddie Bray; Rebecca L Siegel; Jacques Ferlay; Joannie Lortet-Tieulent; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-02-04       Impact factor: 508.702

8.  Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis.

Authors:  Yusuke Tsujimura; Kazushige Obata; Kaori Mukai; Hideo Shindou; Masayuki Yoshida; Hideto Nishikado; Yohei Kawano; Yoshiyuki Minegishi; Takao Shimizu; Hajime Karasuyama
Journal:  Immunity       Date:  2008-03-13       Impact factor: 31.745

Review 9.  5-fluorouracil: mechanisms of action and clinical strategies.

Authors:  Daniel B Longley; D Paul Harkin; Patrick G Johnston
Journal:  Nat Rev Cancer       Date:  2003-05       Impact factor: 60.716

10.  Cancer statistics in China, 2015.

Authors:  Wanqing Chen; Rongshou Zheng; Peter D Baade; Siwei Zhang; Hongmei Zeng; Freddie Bray; Ahmedin Jemal; Xue Qin Yu; Jie He
Journal:  CA Cancer J Clin       Date:  2016-01-25       Impact factor: 508.702

View more
  5 in total

Review 1.  Basophils as a potential therapeutic target in cancer.

Authors:  Jicheng Zhang; Hanlin Yin; Qiangda Chen; Guochao Zhao; Wenhui Lou; Wenchuan Wu; Ning Pu
Journal:  J Zhejiang Univ Sci B       Date:  2021-12-15       Impact factor: 3.066

Review 2.  Dual Effect of Immune Cells within Tumour Microenvironment: Pro- and Anti-Tumour Effects and Their Triggers.

Authors:  Alicia Cristina Peña-Romero; Esteban Orenes-Piñero
Journal:  Cancers (Basel)       Date:  2022-03-25       Impact factor: 6.639

Review 3.  Role of Basophils in a Broad Spectrum of Disorders.

Authors:  Kensuke Miyake; Junya Ito; Hajime Karasuyama
Journal:  Front Immunol       Date:  2022-05-27       Impact factor: 8.786

4.  Association of peripheral basophils with tumor M2 macrophage infiltration and outcomes of the anti-PD-1 inhibitor plus chemotherapy combination in advanced gastric cancer.

Authors:  Chaorui Wu; Yaopeng Qiu; Renyi Zhang; Xiaoqing Li; Huayuan Liang; Minghao Wang; Fengping Li; Mansheng Zhu; Gengtai Ye; Hao Liu; Guoxin Li; Liying Zhao
Journal:  J Transl Med       Date:  2022-09-04       Impact factor: 8.440

Review 5.  Targeting myeloid villains in the treatment with immune checkpoint inhibitors in gastrointestinal cancer.

Authors:  Chie Kudo-Saito; Narikazu Boku; Hidekazu Hirano; Hirokazu Shoji
Journal:  Front Immunol       Date:  2022-09-23       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.